BOSTON--(BUSINESS WIRE)--Nov. 8, 2021--
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that senior management will participate in fireside chats at the following upcoming virtual investor conferences:
Guggenheim 3rd Annual Neuro/Immunology Conference
Date: November 15, 2021
Time: 11:00 a.m. ET
Stifel 2021 Virtual Healthcare Conference
Date: November 16, 2021
Time: 10:40 a.m. ET
A live webcast of the fireside chats will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcasts will also be archived for up to 30 days on Karuna’s website following the conference.
About Karuna Therapeutics
Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by these severe and disabling disorders. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in people's lives. For more information, please visit www.karunatx.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211108005014/en/
Source: Karuna Therapeutics, Inc.